Statistics for Targeting CD133 In Androgen Receptor Indifferent, Neuroendocrine Differentiated Aggressive Variant Prostate Cancer

Total visits

views
Targeting CD133 In Androgen Receptor Indifferent, Neuroendocrine Differentiated Aggressive Variant Prostate Cancer 194

Total visits per month

views
May 2024 1
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
Glumac_umn_0130E_20410.pdf 136

Top country views

views
China 69
United States 67
Canada 6
Hong Kong SAR China 6
Taiwan 6
Ireland 3
Iran 3
Singapore 3
Thailand 3
Australia 2
Germany 2
Denmark 2
Spain 2
India 2
Romania 2
Egypt 1
Finland 1
France 1
United Kingdom 1
Indonesia 1
Iraq 1
South Korea 1
Mongolia 1
Philippines 1
Serbia 1
Russia 1
Turkey 1

Top city views

views
Staten Island 12
Hangzhou 9
Taichung 6
Ashburn 4
Chicago 4
Dublin 4
Longmont 4
Beijing 3
Boardman 3
Minneapolis 3
Saint Paul 3
Singapore 3
Zhengzhou 3
Alexandria 2
Anaheim 2
Baltimore 2
Bangkok 2
Brisbane 2
Cluj-Napoca 2
Dallas 2
Hastings 2
Jiaxing 2
Jinan 2
Rochester 2
Shanghai 2
Tianjin 2
Windsor 2
Agoura Hills 1
Ankara 1
Bad Vilbel 1
Barcelona 1
Boston 1
Brooklyn 1
Burlington 1
Carbondale 1
Central 1
Chandigarh 1
Changzhou 1
Chongqing 1
Coimbatore 1
Copenhagen 1
Dalian 1
Des Moines 1
Dongguan 1
Erbil 1
Espoo 1
Guangzhou 1
Hamilton 1
Huainan 1
Issaquah 1
Las Vegas 1
Limeil-Brevannes 1
Liverpool 1
Los Angeles 1
Malden 1
Moscow 1
New York 1
Ningde 1
Niš 1
Pulandian 1
Putian 1
Roxbury Crossing 1
San Francisco 1
San Sebastián de La Gomera 1
Seoul 1
Shanhu 1
Shaoxing 1
Shenzhen 1
Surrey 1
Tai'an 1
Taizhou 1
The Bronx 1
Toronto 1
Vejle 1
Wuhan 1
Xuzhou 1
Yancheng 1
Yangzhou 1
Yaocheng 1
Zhuhai 1